Run your whole hospital on one system, from the front desk to the ward.
Registration, records, the laboratory, pharmacy, billing, and every other clinical service operate from the same patient record. It reveals likely resistance before empiric antibiotics are prescribed.
Escherichia coli
Your hospital already produces the information it needs. It just doesn't move.
A patient registers at reception, their file is shelved, lab results are printed on paper, the pharmacy dispenses medication without seeing them, billing captures only part of the patient's journey, and critical information is lost along the way. When the patient returns, it's as if they're visiting for the first time.
Nowhere are the consequences more serious than in antibiotic prescribing.
Clinicians frequently have to prescribe empiric antibiotics days before culture results are available. Yet every antimicrobial susceptibility result generated by the laboratory remains locked away in individual patient records, with no facility-wide view of resistance trends by ward, department, or time period. The same resistance patterns are encountered repeatedly, forcing each clinician to make decisions with incomplete information.
Nigerians die each year in infections that antibiotics should have handled. Around 720 people a day. Antimicrobial resistance is what happens when the drugs we rely on stop working against common infections.
Young children carry the heaviest of it. Across low- and middle-income countries most AMR deaths are in children under five, and Nigeria sits in the worst-affected region in the world.
Other systems manage records. Health Scope tells the clinician what to do with them.
The hospital information system is what your facility runs on every morning. The resistance layer is why those results stop dying in the file.
One record per patient
Registration, outpatient clinics, admissions, ward and bed management. One record follows the patient through every visit, instead of starting over at each desk.
The full laboratory
A laboratory information system across every unit, with each susceptibility result stored as structured data rather than a line of text on a slip.
Pharmacy, stock and billing
Dispensing with live stock levels, and every test, drug and consult charged at the point of care, so revenue stops leaking through paper.
Resistance at the prescribing screen
The moment a clinician prescribes, the evidence is already there.
The patient's resistance profile. The laboratory's accumulated knowledge of that organism. All brought together at the point of care, before the prescription is written.
Your own live antibiogram
Built from your own cultures, showing how resistance shifts quarter to quarter. Nothing exported to a separate system, nothing re-entered by hand.
What the patient actually received
We record the drug dispensed, not just the drug prescribed. When the first-line agent isn't in stock and the pharmacy substitutes, we capture it. Very few systems in the country record that, and it is the difference between knowing what clinicians intended and knowing what patients took.
Resistance prediction
The model is trained on a 30,000-isolate synthetic dataset calibrated to NCDC's published AMR reports, and it forecasts likely resistance ahead of a culture returning. Your facility's own cultures sharpen it once you're live: the national picture becomes your picture.
Drug susceptibility
S I RPrevalence ranking
The facility antibiogram, built from your own cultures. Filter by organism or by agent, or select a row in the prevalence ranking. Every organism on the panel is ranked by prevalence, with first-isolate deduplication applied per CLSI. Demo environment, synthetic dataset calibrated to NCDC's published AMR reports. Try the filters.
One patient. One record. Every department connected.
Everything below ships in the platform. Not a roadmap, and not a module you pay extra for later.
Clinical & Laboratory
- Patient registrationand one record per patient, across every visit
- Outpatient clinicsqueues and appointment scheduling
- Inpatient admissionsward and bed management
- Clinical notesdiagnoses, vitals and patient history
- Laboratory information systemacross all departments
- Nursing observationsand charting at the bedside
- Result-ready alertsto the clinician, and patient updates by email, WhatsApp or SMS
Operations & Revenue
- Order entryfor laboratory, pharmacy, imaging and every clinical service, from one screen
- Pharmacy dispensingwith live stock levels and reorder points
- Billing and invoicingat the point of care, so charges are captured while the patient is still in front of you
- Cashier and payment recordingwith order gating where needed
- Staff accountswith role-based access
- Drug and consumable inventorywith reorder alerts
Compliance & Reporting
- NHIA and HMO claimsprepared from records already in the system
- DHIS2 and national returnsgenerated instead of retyped by hand
- Notifiable disease reportingready for IDSR submission
- Infection prevention & controlreports for your IPC committee
Security & Data Protection
- FHIR-aligned recordsso your data stays yours and stays portable
- Role-based accessso staff see only what their job needs
- A full audit trailof who saw and changed each record
- Encrypted in transit and at restwith daily backups, aligned with the Nigeria Data Protection Act
One patient record, read by every department at once.
This is a single admitted patient. The front desk, the pharmacy, the lab, the ward and billing are all writing to the same record, in real time. Scroll the record below, or jump to what each role sees.
Medications
Prescribed and dispensed →| Prescribed | Ordered by | Dispensed | Status |
|---|---|---|---|
Metformin 1 g BD Regular, continued on admission |
Dr E. Adeniyi | Metformin 1 g BD Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
Metronidazole 400 mg TDS 4 Jul 19:10 |
Dr E. Adeniyi | →Tinidazole 500 mg BD Pharm. T. Ojo, 4 Jul 19:44 |
Substituted · out of stock |
Enoxaparin 40 mg OD SC VTE prophylaxis, 4 Jul 20:00 |
Dr E. Adeniyi | Enoxaparin 40 mg OD SC Pharm. T. Ojo, 4 Jul 20:15 |
Dispensed as prescribed |
Nitrofurantoin 100 mg QDS Culture-directed, 6 Jul 14:05 |
Dr E. Adeniyi | Nitrofurantoin 100 mg QDS Pharm. T. Ojo, 6 Jul 15:20 |
Dispensed as prescribed |
Paracetamol 1 g TDS PRN 4 Jul 19:10 |
Dr E. Adeniyi | Paracetamol 1 g TDS PRN Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
Investigations
All results →Vitals
9 Jul, 06:00Clinical note
9 Jul, 08:22Day 5 post-laparotomy. Comfortable overnight, pain controlled on oral analgesia. Mobilising to the corridor with one nurse, tolerating a soft diet. Wound clean and dry, staples intact. Glycaemic control steady on her usual metformin. Nitrofurantoin continues for the urinary isolate. For discharge planning review on Friday.
Diagnoses & alerts
Procedures
Full history →Payments
Role: ClinicianDiagnoses & alerts
Clinical note
9 Jul, 08:22Day 5 post-laparotomy. Comfortable overnight, pain controlled on oral analgesia. Mobilising to the corridor with one nurse, tolerating a soft diet. Wound clean and dry, staples intact. Glycaemic control steady on her usual metformin. Nitrofurantoin continues for the urinary isolate. For discharge planning review on Friday.
| Prescribed | Ordered by | Dispensed | Status |
|---|---|---|---|
Metformin 1 g BD Regular, continued on admission |
Dr E. Adeniyi | Metformin 1 g BD Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
Metronidazole 400 mg TDS 4 Jul 19:10 |
Dr E. Adeniyi | →Tinidazole 500 mg BD Pharm. T. Ojo, 4 Jul 19:44 |
Substituted · out of stock |
Enoxaparin 40 mg OD SC VTE prophylaxis, 4 Jul 20:00 |
Dr E. Adeniyi | Enoxaparin 40 mg OD SC Pharm. T. Ojo, 4 Jul 20:15 |
Dispensed as prescribed |
Nitrofurantoin 100 mg QDS Culture-directed, 6 Jul 14:05 |
Dr E. Adeniyi | Nitrofurantoin 100 mg QDS Pharm. T. Ojo, 6 Jul 15:20 |
Dispensed as prescribed |
Paracetamol 1 g TDS PRN 4 Jul 19:10 |
Dr E. Adeniyi | Paracetamol 1 g TDS PRN Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
One record, one screen. Diagnoses, procedures, prescriptions, clinical notes, prior tests and results, and payment status, all against the same patient. The medications table shows the drug prescribed beside the drug actually dispensed, so a stock-out is captured rather than lost. Interface preview, in build. Demo environment with synthetic data.
What we've already built.
Published AMR research
Peer-reviewed, UMYU Journal of Microbiology Research, 2023.
Hospital information system MVP
The core lab and resistance workflow is specified and built, ready for pilot facilities to generate real data.
NCDC engagement
In active conversation with NCDC on positioning Health Scope as a complementary facility-level layer to national surveillance. Technical Working Group invitation extended.
Registered company
AMR Scope Nigeria Limited, CAC registered.
AMR intelligence layer
Built and deployed, calibrated to NCDC AMR reports.
Clinical validation
30 health workers surveyed across tertiary, general and private facilities.
First pilots being secured
Pilot facilities being lined up in Abuja, with a letter of intent in progress through our clinical lead.
NDPA-ready from day one
Registered with the NDPC, with a DPIA, appointed DPO, encryption and role-based access.
Built by Nigerian healthcare practitioners.
We've worked in these hospitals and laboratories ourselves. We understand the daily challenges clinicians, laboratory scientists, pharmacists and administrators face, because we've faced them. Health Scope was built around those realities, not adapted from a foreign template.
Abimbola Nurudeen Oba
Medical Laboratory Scientist and data engineer, four years clinical. Published AMR researcher. Built the prototype and the machine learning layer.
Kehinde Jejelaye
Backend engineer. Responsible for the production build, the clinical data layer and system security.
Dr. Mardiyyah Salah
Clinician. Validated the clinical workflows the platform is built on and advised on the research behind the resistance layer, from the first sketch onwards.
Ajumobi Abdulbasit
Pharmacist and human-centred design researcher with a drug-research background. Shaped the platform around the people who use it, and opened the first clinician conversations. Leads pharma engagement and clinical adoption.
Bello Abdulazeez
Leads the conversations with our first pilot hospital, working towards a letter of intent, and stress-tests every assumption we make about how a facility actually runs.
A Nigeria where no patient dies from an infection we could have treated.
Because their clinician had the right information at the right time. Health Scope exists to bring down the antimicrobial resistance mortality rate in Nigeria.
Where you come in.
You run a facility
Cloud where connectivity allows it, on-premise or hybrid where it does not. Most facilities go live in four to eight weeks. Billing, stock and claims stop leaking on day one; the resistance layer starts paying off the moment your own cultures accumulate.
Scope a pilotYou fund health innovation
A CAC-registered, NDPA-compliant company with peer-reviewed AMR research behind it, a built MVP, and active NCDC engagement. Roughly 2,500 private secondary and tertiary hospitals in Nigeria run laboratories. The overwhelming majority of them prescribe antibiotics blind.
Request the deckYou work in national surveillance
Anonymised, aggregated resistance data can feed national surveillance with NCDC. A live facility-level signal, updating as cultures come off the bench, which paper reporting has never been able to produce.
Talk data sharingLet's scope a pilot at your facility.
Whether you run a hospital, fund health innovation, or work in national surveillance, we'd like to talk.
hello@abimbolaoba.com · +234 812 311 7213